Form 4 Filing for George W. Dunbar Jr. - CAPRICOR THERAPEUTICS, INC.

This filing details a transaction by George W. Dunbar Jr., a director at CAPRICOR THERAPEUTICS, INC. (CAPR), on December 19, 2025. Dunbar exercised a stock option to purchase 3,000 shares of common stock at an exercise price of $1.39 per share. This option, originally granted on June 2, 2016, was adjusted due to a 1-for-10 reverse stock split and a subsequent repricing. Following the exercise, Dunbar acquired 3,000 shares, increasing his post-transaction holdings to 14,306 shares of common stock. The filing also notes that the exercised option was fully vested as of December 31, 2016. The transaction code is "M" for a purchase (acquired), and the ownership nature is direct.